Xiamen, China

Lina Lin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Xiamen University, Yang Sheng Tang Company Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lina Lin. Retrieved from https://idiyas.com/inventor/lina-lin-xu1t3p8o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lina Lin - Innovator in Tumor Treatment

Introduction

Lina Lin is a prominent inventor based in Xiamen, China. She has made significant contributions to the field of medical research, particularly in the treatment of tumors. Her innovative approach utilizes a modified pseudorabies virus to combat tumor growth and recurrence.

Latest Patents

Lina Lin holds a patent for a pseudorabies virus designed for treating tumors. This patent outlines a method that involves administering the pseudorabies virus or its modified form to subjects in need. The invention aims to reduce or inhibit tumor recurrence, providing a new avenue for pharmaceutical compositions aimed at treating tumors.

Career Highlights

Throughout her career, Lina Lin has worked with esteemed institutions such as Xiamen University and Yang Sheng Tang Company Limited. Her work has been pivotal in advancing the understanding and treatment of tumors, showcasing her dedication to medical innovation.

Collaborations

Lina has collaborated with notable colleagues, including Yixin Chen and Guosong Wang. These partnerships have further enriched her research and contributed to her success in the field.

Conclusion

Lina Lin's innovative work in tumor treatment exemplifies the impact of research and invention in medicine. Her contributions continue to inspire advancements in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…